WATCH 🎥: Veda Giri, MD, discusses national and international guideline recommendations for germline testing in prostate cancer. www.urologytimes.com/view/veda-gi...

The FDA has granted breakthrough device designation to the Virtuoso Surgical Robotic System for bladder lesion removal via en bloc excision. www.urologytimes.com/view/fda-gra...

WATCH 🎥: Veeru Kasivisvanathan, MBBS, BSc, FRCS, MSc, PGCert, PhD, discusses findings from the PRIME trial, a multicenter, international study on the diagnostic performance of bpMRI vs mpMRI in prostate cancer detection. www.urologytimes.com/view/prime-t...

BREAKING🚨: The FDA has approved pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection across previously approved solid tumor indications of intravenous pembrolizumab. www.urologytimes.com/view/fda-app...

In this episode of First Assist: GU Oncology Unpacked, host Taylor Goodstein, MD, speaks with Kamal Pohar, MD, about the evolution of management and surveillance for NMIBC. www.urologytimes.com/view/first-a...

BREAKING🚨: The #FDA has approved Medtronic's Altaviva device, an implantable tibial neuromoulation therapy for patients with urge urinary incontinence. www.urologytimes.com/view/fda-app...

Additional results from the RAPID I study suggest that the FloStent device could serve as an effective interim solution for men with urinary retention due to BPH who are awaiting TURP. www.urologytimes.com/view/flosten...

Carotuximab in combination with apalutamide achieved encouraging progression-free survival in patients with mCRPC. www.urologytimes.com/view/carotux...

The Dornier Hoover Flexible and Navigable Suction Ureteral Access Sheath and Dornier Axis II Slim single-use ureteroscope are now commercially available in the US. www.urologytimes.com/view/dornier...

WATCH 🎥: Jane T. Kurtzman, MD, discusses findings from her study on the long-term risk of hypertension following renal trauma. www.urologytimes.com/view/data-po...

WATCH 🎥: John P. Sfakianos, MD, discusses the use of urine-based tumor markers to guide decision-making in hematuria evaluation. www.urologytimes.com/view/john-p-...

WATCH 🎥: A. Lenore Ackerman, MD, PhD, discusses the renewed emphasis on symptom resolution over microbial eradication for treatment success in the updated AUA guideline for recurrent uUTI in women. www.urologytimes.com/view/recurre...

Biparametric MRI was found to be noninferior to multiparametric MRI in the detection of clinically significant prostate cancer, according to recent findings from the PRIME trial. www.urologytimes.com/view/biparam...

Andrew J. Kirsch, MD, FAAP, FACS, outlines current gaps and opportunities in enuresis treatment. www.urologytimes.com/view/a-pedia...

WATCH 🎥: Stephen J. Freedland, MD, highlights the role of diet in prostate cancer management. www.urologytimes.com/view/stephen...

In a recent interview with Urology Times, Sia Daneshmand, MD, shared his thoughts on the recent #FDA approval of the gemcitabine intravesical system (Inlexzo; formerly TAR-200) for BCG-unresponsive NMIBC. Find his insights here: www.urologytimes.com/view/behind-...

Andrea B. Apolo, MD, discusses immune checkpoint inhibition as adjuvant and perioperative therapy in MIBC. www.urologytimes.com/view/andrea-...

New 2-year outcomes from the ASPIRE trial were presented at #WCET25, showing that patients who underwent the SURE procedure had a lower risk of health care consumption events than those who underwent URS. www.urologytimes.com/view/sure-pr...

Japan’s Pharmaceuticals and Medical Devices Agency has accepted for review a new drug application for nadofaragene firadenovec in high-risk BCG-unresponsive NMIBC. www.urologytimes.com/view/nadofar...

Data from a phase 1b study showed encouraging preliminary symptom improvement with sunobinop in patients with interstitial cystitis/bladder pain syndrome. www.urologytimes.com/view/sunobin...

BREAKING🚨: The FDA has approved gemcitabine intravesical system (Inlexzo; formerly TAR-200) for adult patients with BCG-unresponsive NMIBC with CIS with or without papillary tumors. www.urologytimes.com/view/fda-app...

WATCH 🎥: Henry C. Wright IV, MD, and Jennifer Miles-Thomas, MD, URPS, MBA, highlighted Northwestern Medicine Urology’s successful integration of AI technology into clinical practice. www.urologytimes.com/view/physici...

Jonathan Rubenstein, MD, and Mark Painter summarize key provisions outlined in the Medicare proposed rule for 2026. www.urologytimes.com/view/medicar...

Rana McKay, MD, FASCO, outlines key takeaways from the COMRADE trial of olaparib plus radium-223 in CRPC. www.urologytimes.com/view/key-tak...

Kevin Koo, MD, MPH, recently sat down with Urology Times to discuss a study on the impact of a digital stone measurement tool on surgeon decision-making during ureteroscopy. www.urologytimes.com/view/kevin-k...

WATCH 🎥: Stephen J. Freedland, MD, discusses findings from a recent systematic review examining the relationship between diet and prostate cancer risk and outcomes. www.urologytimes.com/view/systema...

Updated data from cohort C of the BOND-003 trial show consistent efficacy and favorable tolerability with cretostimogene grenadenorepvec in patients with high-risk BCG-unresponsive NMIBC. Learn more: www.urologytimes.com/view/updated...

Investigators at Johns Hopkins Medicine and collaborating institutions have developed a noninvasive urine test that shows strong promise in detecting prostate cancer. www.urologytimes.com/view/urine-b...

The pivotal cohort in the phase 2 LEGEND trial, exploring detalimogene voraplasmid in high-risk NMIBC, has reached its enrollment goal. www.urologytimes.com/view/pivotal...

The enrollment goal has been met in the phase 3 PIVOT-006 trial, which is comparing RFS with cretostimogene grenadenorepvec vs surveillance following TURBT in patients with IR-NMIBC. www.urologytimes.com/view/enrollm...

The American Cancer Society has released its annual Prostate Cancer Statistics report, showing increasing incidence rates alongside slowing declines in mortality. www.urologytimes.com/view/acs-rep...

Take a look through our latest monthly recap, where we dive into the top 5 stories in urologic oncology from August 2025! Sign up🔓 to view: www.urologytimes.com/view/top-5-u...

Predicine has begun the FDA premarket approval process for its urine cfDNA NGS assay, PredicineCARE, as a companion diagnostic in bladder cancer. www.urologytimes.com/view/premark...

Hong Truong, MD, highlights key findings from a study evaluating the utilization of genetic counseling and testing in patients with kidney cancer. www.urologytimes.com/view/hong-tr...

Take a look back through last month's FDA decisions in urology in our latest regulatory recap! www.urologytimes.com/view/fda-upd...

Sandip Prasad, MD, outlines 3 key takeaways from the ENVISION trial, which supported the approval of mitomycin for intravesical solution in patients with LG-IR-NMIBC. www.urologytimes.com/view/sandip-...

The American College for Surgeons has released new guidelines on best practices for the management of genitourinary injuries. Learn more: www.urologytimes.com/view/acs-rel...

BREAKING🚨: The #FDA has approved a 3-month formulation of leuprolide mesylate (Camcevi ETM; 21 mg) long-acting injectable for patients with advanced prostate cancer. www.urologytimes.com/view/fda-app...

Rana McKay, MD, FASCO, outlines key findings from the phase 2 COMRADE trial, evaluating olaparib plus radium-223 in patients with CRPC with bone metastases. www.urologytimes.com/view/rana-mc...

BREAKING 🚨: The FDA has issued a complete response letter on the biologics license application for 89Zr-DFO-girentuximab, an investigational agent for PET imaging of ccRCC. www.urologytimes.com/view/fda-iss...

WATCH🎥: Timothy McClure, MD, offers his thoughts on how future advancements will inform the role for focal therapy in prostate cancer. www.urologytimes.com/view/timothy...

In a recent interview with Urology Times, Christopher Weight, MD, MS, of @clevelandclinic.bsky.social shared his thoughts on the current state and directions of AI in prostate cancer. www.urologytimes.com/view/ai-and-...

WATCH🎥: Jennifer Robles, MD, MPH, discusses the future for HoLEP in terms of innovation and wider integration into clinical practice. www.urologytimes.com/view/jennife...

In the latest episode of Pearls & Perspectives, host Amy Pearlman, MD, speaks with Adam Gvili, PT, DPT, about his personal and professional journey in treating male pelvic floor dysfunction. www.urologytimes.com/view/pearls-...

Health Canada has approved darolutamide plus ADT for the treatment of adult patients with mCSPC. www.urologytimes.com/view/health-...

Kevin Shee, MD, PhD, shares recent study findings on factors associated with recurrence and treatment failure following HIFU for prostate cancer. www.urologytimes.com/view/kevin-s...

Sulopenem etzadroxil and probenecid oral tablets are now commercially available in the US for patients with uncomplicated urinary tract infections. www.urologytimes.com/view/oral-su...

Check out the first episode of the First Assist Podcast, brought to you by Urology times @urologytimes.bsky.social

Novel MISTs are reshaping #BPH management, helping patients achieve symptom relief while preserving sexual function. In a recent editorial, Kevin Zorn, MD, reviews FDA-cleared options and discusses the shift toward personalized treatment. www.urologytimes.com/view/persona...

Timothy McClure, MD, outlines key findings from the PRESERVE trial, which evaluated IRE for prostate tissue ablation in patients with intermediate-risk prostate cancer. www.urologytimes.com/view/timothy...